Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Merck KGaA
  6. Summary
    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 07/26 03:58:59 pm
172.075 EUR   -1.08%
02:58aMARKETMIND : A China crackdown
RE
07/23MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN : KGaA Appoints China, International Markets' Health Head
MT
07/23MERCK KGAA : JP Morgan reiterates its Buy rating
MD
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
07/20/2021 07/21/2021 07/22/2021 07/23/2021 07/26/2021 Date
168.25(c) 167.65(c) 170.05(c) 173.95(c) 171.85 Last
312 761 325 973 240 854 344 260 206 250 Volume
-0.68% -0.36% +1.43% +2.29% -1.21% Change
More quotes
Estimated financial data (e)
Sales 2021 18 906 M 22 315 M 22 315 M
Net income 2021 2 580 M 3 045 M 3 045 M
Net Debt 2021 8 828 M 10 420 M 10 420 M
P/E ratio 2021 28,6x
Yield 2021 0,88%
Sales 2022 19 885 M 23 470 M 23 470 M
Net income 2022 2 754 M 3 251 M 3 251 M
Net Debt 2022 6 771 M 7 991 M 7 991 M
P/E ratio 2022 26,9x
Yield 2022 0,93%
Capitalization 74 717 M 88 244 M 88 188 M
EV / Sales 2021 4,42x
EV / Sales 2022 4,10x
Nbr of Employees 57 850
Free-Float 29,7%
More Financials
Company
Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Performance Materials. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The... 
Sector
Pharmaceuticals
Calendar
08/05 | 01:00amEarnings Release
More about the company
Ratings of Merck KGaA
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about MERCK KGAA
02:58aMARKETMIND : A China crackdown
RE
07/23MERCK KOMMANDITGESELLSCHAFT AUF AKTI : KGaA Appoints China, International Market..
MT
07/23MERCK KGAA : JP Morgan reiterates its Buy rating
MD
07/23MARKETMIND : Lower forever for 'Generation T'?
RE
07/22MERCK : Launches Green Solvents Line for Semiconductor Manufacturers
MT
07/22MARKETMIND : Expect ECB doves to coo
RE
07/22DGAP-PVR : Merck KGaA: Release according to Article 40, Section 1 of the WpHG [t..
DJ
07/21MARKETMIND : A rocky road
RE
07/20MARKETMIND : After the storm
RE
07/19MERCK : to Expand Darmstadt HQ in Germany for $318 Million
MT
07/19MERCK KGAA : Barclays remains Neutral
MD
07/19MARKETMIND : Freedom day on Love Island
RE
07/16MARKETMIND : What if transitory is not so transitory after all?
RE
07/15MERCK : Signs Contract To Manufacture Schistosomiasis' Drug In Kenya
MT
07/15MARKETMIND : "A ways off" and that's good
RE
More news
News in other languages on MERCK KGAA
07/19DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 19.07.2021 - 15.15 Uhr
07/19Merck investiert 270 Millionen in Forschungs- und Ausbildungszentrum
07/19Merck investiert 270 Mio EUR in Forschungs- und Weiterbildungszentrum
07/15Merck erhält in Großbritannien positive Beurteilung für Tepotinib
07/15Merck lässt neues Bilharziose-Medikament für Kinder in Kenia herstellen
More news
Analyst Recommendations on MERCK KGAA
More recommendations
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | MarketScreener
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 171,85 €
Average target price 155,63 €
Spread / Average Target -9,44%
EPS Revisions
Managers and Directors
BelÚn Garijo Lˇpez Chairman-Executive Board & CEO
Marcus Kuhnert Chief Financial Officer
Wolfgang Heinz BŘchele Chairman-Supervisory Board
Nilesh Kumar Senior Investment Director
Christian Raabe Member-Supervisory Board
Sector and Competitors